منابع مشابه
Combined Hepatocellular and Cholangiocarcinoma with Sarcomatous Transformation
Combined hepatocellular and cholangiocarcinoma with sarcomatous transformation was first recognized in Ramathibodi Hospital in 2005. This variant of carcinoma has been increasingly reported particularly from Asian countries. Dedifferentiation of the epithelial component to various sarcomatous components is likely the underlying mechanism. The causative factors of hepatocarcinogenesis in Thailan...
متن کاملExophytic combined hepatocellular carcinoma and cholangiocarcinoma
Combined hepatocellular carcinoma and cholangiocarcinoma (combined HCC-CC) is a rare subtype of liver cancer displaying components of both hepatocellular and cholangiocellular carcinoma. Not only are exophytic liver tumors very rare, but their diagnosis presents a challenge due to the uncertainty of the tumor origin. In this issue, we present a case of exophytic combined HCC-CC with unusual mor...
متن کاملDigestive organs: Liver: Combined hepatocellular and cholangiocarcinoma
The reported frequency of combined hepatocellular and cholangiocarcinoma (combined tumors) varies widely; 1.0-6.5% among patients with primary liver cancer. Statistical data indicate that combined tumors occur predominantly in men (reported ratio is ranged from 14:1 to 2:1). The mean age of onset is in the sixth decade. In Asian cases, a high incidence of hepatitis B or C virus infection and fr...
متن کاملCurrent update on combined hepatocellular-cholangiocarcinoma
Combined hepatocellular-cholangiocarcinoma is a rare but unique primary hepatic tumor with characteristic histology and tumor biology. Recent development in genetics and molecular biology support the fact that combined hepatocellular-cholangiocarcinoma is closely linked with cholangiocarcinoma, rather than hepatocellular carcinoma. Combined hepatocellular cholangiocarcinoma tends to present wit...
متن کاملClinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma
Combined hepatocellular-cholangiocarcinoma (CHC) is a rare tumor with poor prognosis, with incidence ranging from 1.0%-4.7% of all primary hepatic tumors. This entity will be soon renamed as hepato-cholangiocarcinoma. The known risk factors for hepatocellular carcinoma (HCC) have been implicated for CHC including viral hepatitis and cirrhosis. It is difficult to diagnose this tumor pre-operativ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medicine
سال: 2019
ISSN: 0025-7974,1536-5964
DOI: 10.1097/md.0000000000017102